2015
DOI: 10.1016/j.atherosclerosis.2014.12.059
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence – Estimates from the Finnish prescription register

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0
1

Year Published

2016
2016
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 39 publications
0
19
0
1
Order By: Relevance
“…23 In Finland, an analysis of cost-effectiveness of statins for primary prevention gave monitoring costs for patients taking statins for primary prevention as €147.90 (£108.59) per annum, based on one additional doctor consultation, nurse consultation, and blood test per year. 24 Lilford et al have reviewed liver function testing in the wider context of liver disease and also highlighted the cost implications of a reduced analyte panel. 9,25 Implications for practice Prices for laboratory testing vary substantially.…”
Section: Comparison With Existing Literaturementioning
confidence: 99%
“…23 In Finland, an analysis of cost-effectiveness of statins for primary prevention gave monitoring costs for patients taking statins for primary prevention as €147.90 (£108.59) per annum, based on one additional doctor consultation, nurse consultation, and blood test per year. 24 Lilford et al have reviewed liver function testing in the wider context of liver disease and also highlighted the cost implications of a reduced analyte panel. 9,25 Implications for practice Prices for laboratory testing vary substantially.…”
Section: Comparison With Existing Literaturementioning
confidence: 99%
“…6 Of Finnish statin users, just 60% were found to be adherent with their regimen after 4 years. 7 Poor medication adherence may result in unplanned hospitalizations, adverse clinical outcomes, and increased costs. 8 Home health care involves multiple steps in the transfer of information and medicines from the prescriber to a patient and subsequent actions by that patient.…”
Section: Introductionmentioning
confidence: 99%
“…12,37,38,39 Importantly, patients with poor adherence are more likely to have a higher incidence of cardiovascular and cerebrovascular events and all-cause mortality than adherent patients. [14][15][16]40 In addition, recent results showed that treatment adherence plays an important role in the cost-effectiveness of statin treatment in primary prevention, 41 such that one of the first-line strategies to improve statin effectiveness recommended in primary care is to implement interventions focused on improving adherence that take into consideration patient, GP, and health system characteristics. 42 Our results on goal attainment when only adherent (MPR .…”
Section: Discussionmentioning
confidence: 99%